NCT01157182View on ClinicalTrials.gov

Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Healthy
Interventions
DRUG

Estradiol/Norethindrone acetate

1/0.5 mg Tablets

DRUG

Activella®

1/0.5 mg Tablets

Trial Locations (1)

M1L 4S4

Biovail Clinical Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01157182 - Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting Conditions | Biotech Hunter | Biotech Hunter